NDC 33261-020

cephalexin

Cephalexin

cephalexin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aidarex Pharmaceuticals Llc. The primary component is Cephalexin Anhydrous.

Product ID33261-020_9e4f9fd2-cd74-4527-8b28-4688f72cdf6f
NDC33261-020
Product TypeHuman Prescription Drug
Proprietary Namecephalexin
Generic NameCephalexin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2010-06-21
Marketing CategoryANDA / ANDA
Application NumberANDA062791
Labeler NameAidarex Pharmaceuticals LLC
Substance NameCEPHALEXIN ANHYDROUS
Active Ingredient Strength500 mg/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 33261-020-28

28 CAPSULE in 1 BOTTLE (33261-020-28)
Marketing Start Date2010-06-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 33261-020-40 [33261002040]

cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062791
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-21
Inactivation Date2020-01-31

NDC 33261-020-88 [33261002088]

cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062791
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-06-21
Inactivation Date2020-01-31

NDC 33261-020-28 [33261002028]

cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062791
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-21
Inactivation Date2020-01-31

NDC 33261-020-30 [33261002030]

cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062791
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-21
Inactivation Date2020-01-31

NDC 33261-020-20 [33261002020]

cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062791
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-21
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CEPHALEXIN ANHYDROUS500 mg/1

OpenFDA Data

SPL SET ID:cab0d668-f4a4-4848-ba93-fa2c2246096c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309112
  • 309114
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "cephalexin" or generic name "Cephalexin"

    NDCBrand NameGeneric Name
    0093-2238CephalexinCephalexin
    0093-2240CephalexinCephalexin
    0093-3145CephalexinCephalexin
    0093-3147CephalexinCephalexin
    0093-4175CephalexinCephalexin
    0093-4177CephalexinCephalexin
    0143-9769CephalexinCephalexin
    0143-9770CephalexinCephalexin
    0143-9897CephalexinCephalexin
    0143-9898CephalexinCephalexin
    67877-220CephalexinCephalexin
    67877-254CephalexinCephalexin
    67877-255CephalexinCephalexin
    67877-219CephalexinCephalexin
    68071-1585CephalexinCephalexin
    68071-4177CephalexinCephalexin
    68071-3186CephalexinCephalexin
    68071-4355CephalexinCephalexin
    68071-4342CephalexinCephalexin
    68071-4465CephalexinCephalexin
    68071-4233CephalexinCephalexin
    68071-4406CephalexinCephalexin
    68071-4429CephalexinCephalexin
    68071-4587CephalexinCephalexin
    68071-4516CephalexinCephalexin
    68071-4434CephalexinCephalexin
    0440-1243CephalexinCephalexin
    0440-7244CephalexinCephalexin
    68180-124cephalexincephalexin
    68180-441cephalexincephalexin
    68180-121CephalexinCephalexin
    68180-123cephalexincephalexin
    68180-440cephalexincephalexin
    68180-122CephalexinCephalexin
    68788-8986CephalexinCephalexin
    68788-9404CephalexinCephalexin
    68788-7271CephalexinCephalexin
    68788-9713CephalexinCephalexin
    68788-9326CephalexinCephalexin
    68788-9951cephalexincephalexin
    68788-8994CephalexinCephalexin
    68788-7391CephalexinCephalexin
    68788-9539CephalexinCephalexin
    68788-9950cephalexincephalexin
    68788-9956cephalexincephalexin
    68788-9538CephalexinCephalexin
    68788-9752cephalexincephalexin
    68788-9957cephalexincephalexin
    69543-102CephalexinCephalexin
    69778-930CephalexinCephalexin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.